Topic: How To Invest

Q: Hello, Pat. I’ve been quite content in my investments knowing that your professional decisions have been very good. I recently heard about Vicarious Surgical. What do you think of this stock? Thanks.

Article Excerpt

A: Vicarious Surgical Inc., $3.88, symbol RBOT on New York (Shares outstanding: 102.0 million; Market cap: $482.0 million; www.vicarioussurgical.com), was founded in 2014. The company aims to develop what it sees as a disruptive technology to increase the efficiency of surgical procedures, improve patient outcomes, and reduce healthcare costs. The company’s surgical approach uses its exclusive human-like surgical robots to perform minimally invasive surgery. Vicarious went public last year in a $1.1 billion SPAC deal with D8 Holdings. Like most SPACs, Vicarious started trading on Nasdaq around $10 a share, in the late summer of 2020. It hovered around that level for a year, then shot up to $16 on news of its entry into the robotic surgery business. It got back down to $10 at the start of 2022, and hit a low below $3 in mid-year. Like a lot of SPAC deals, this one has yet to make any sales. However, Vicarious believes that it’s moving forward on regulatory and commercial…

You are trying to access subscriber-only content.

To read this article, you may subscribe or sign in.
If you are already a subscriber, log in here.

If you wish to become a subscriber, click here. Or you may enjoy access to all our publications when you become a Member of Pat McKeough's Inner Circle Pro.